Transcranial Pulse Stimulation (TPS) is an alternative non-drug therapeutic concept for the treatment of patients with Alzheimer’s Disease (AD) which is based on low-energy shock

Researchers are probing into REM sleep behavior disorder (RBD), a condition where people physically act out their dreams. This parasomnia is more than a nocturnal

Dementia is an age-related disease, currently known as a major neurocognitive disorder (NCD), is a worldwide health burden. Interventions that aim to ameliorate cognitive decline

A new study identified markers in eye scans which can detect the presence of Parkinson’s disease an average of seven years before clinical presentation. This

Knee ligament injuries represent the most frequent injuries of the musculoskeletal system. Injuries of the anterior cruciate ligament (ACL) are common among professional and recreational

The treatment of therapy-resistant depression is a major challenge in everyday clinical practice and affects about one third of all depressive patients. Due to specific

Parkinson’s disease is a common, incurable neurodegenerative disorder that is clinically heterogeneous: it is likely that different cellular mechanisms drive the pathology in different individuals.

Transcranial Pulse Stimulation (TPS) uses shockwaves for the treatment of Alzheimer ́s patients and is CE-marked. Data from uncontrolled trials is available and a placebo-controlled trial

Trauma-induced Alzheimer’s disease (AD) is rapidly emerging as a major consequence of traumatic brain injuries (TBI), with devastating social and economic impacts. Unfortunately, few treatment

Researchers will explore how light physical activities like walking can affect cognition in older adults at risk for Alzheimer’s or related dementias. Unlike previous studies